<p>Of 284 women positive for high-risk human papillomavirus (HR-HPV) and cytological findings of low-grade squamous intraepithelial or lower-grade lesions at enrollment who were evaluated at the 1-year follow-up assessment, 122 returned for the 2-year follow-up. Clearance in the 1-year follow-up group was defined as HPV positivity at baseline with HPV negativity after 1 year; similarly, persistence in the 1-year follow-up group was defined as HPV positivity both at baseline and 1 year later. Clearance and persistence of the 2-year follow-up group were defined as HPV positivity at baseline with HPV negativity and HPV positivity after 2 years, respectively, regardless of intermediate results. HR-HPV status was determined using the commercial ...
Background: We analyzed data from a cohort of 553 women enrolled in the placebo arm of a randomized ...
Little is known about the factors that influence clearance of human papillomavirus (HPV), the primar...
Detection of persistent cervical carcinogenic human papillomavirus (HPV) DNA is used as a marker for...
Contains fulltext : 95972.pdf (publisher's version ) (Open Access)OBJECTIVE: To ev...
Persistent high-risk (HR) human papillomavirus (HPV) infection is necessary for development of precu...
Background: The design of new healthcare schemes which involve using molecular HPV screening means t...
Background Human papillomavirus (HPV) persistence is the pivotal event in cervical carcinogenesis. W...
To evaluate hr-HPV persistence and associated risk factors in a prospective cohort of young unscreen...
Persistent high-risk human papillomavirus (HR-HPV) infection is the strongest risk factor for high-g...
AbstractPersistence of high-risk (HR-) human papillomavirus (HPV) infection of the uterine cervix in...
Human papilloma virus (HPV) infection persistence is responsible for modifications that will lead to...
Background Human Papillomavirus (HPV) testing has been evaluated as a test of cure in patients foll...
Objective: Human papillomavirus (HPV) has been recognized as the major etiologic agent of cervical s...
Little is known about the dynamics of human papillomavirus (HPV) infection and subsequent developmen...
Objective: To evaluate how the duration of human papillomavirus (HPV) persistence influences the ris...
Background: We analyzed data from a cohort of 553 women enrolled in the placebo arm of a randomized ...
Little is known about the factors that influence clearance of human papillomavirus (HPV), the primar...
Detection of persistent cervical carcinogenic human papillomavirus (HPV) DNA is used as a marker for...
Contains fulltext : 95972.pdf (publisher's version ) (Open Access)OBJECTIVE: To ev...
Persistent high-risk (HR) human papillomavirus (HPV) infection is necessary for development of precu...
Background: The design of new healthcare schemes which involve using molecular HPV screening means t...
Background Human papillomavirus (HPV) persistence is the pivotal event in cervical carcinogenesis. W...
To evaluate hr-HPV persistence and associated risk factors in a prospective cohort of young unscreen...
Persistent high-risk human papillomavirus (HR-HPV) infection is the strongest risk factor for high-g...
AbstractPersistence of high-risk (HR-) human papillomavirus (HPV) infection of the uterine cervix in...
Human papilloma virus (HPV) infection persistence is responsible for modifications that will lead to...
Background Human Papillomavirus (HPV) testing has been evaluated as a test of cure in patients foll...
Objective: Human papillomavirus (HPV) has been recognized as the major etiologic agent of cervical s...
Little is known about the dynamics of human papillomavirus (HPV) infection and subsequent developmen...
Objective: To evaluate how the duration of human papillomavirus (HPV) persistence influences the ris...
Background: We analyzed data from a cohort of 553 women enrolled in the placebo arm of a randomized ...
Little is known about the factors that influence clearance of human papillomavirus (HPV), the primar...
Detection of persistent cervical carcinogenic human papillomavirus (HPV) DNA is used as a marker for...